Clinical and Economic Aspects of <i>KRAS </i>Mutational Status as Predictor for Epidermal Growth Factor Receptor Inhibitor Therapy in Metastatic Colorectal Cancer PatientsRobert Königsberg, Christian Dittrich, M. Klimpfinger et al.|Oncology|2011Cited by 13